CARsgen Therapeutics Holdings Limited
CRTHF
$0.76
$0.01351.81%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1,223.48% | 1,836.90% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1,223.48% | 1,836.90% | -- | -- | -- |
| Cost of Revenue | 779.08% | 1,295.90% | -- | -- | -- |
| Gross Profit | 2,522.39% | 3,417.05% | -- | -- | -- |
| SG&A Expenses | -27.80% | -5.73% | 20.26% | 17.18% | 12.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 101,682.14% | 3,337.23% | 1,704.81% | 614.23% | 99.25% |
| Total Operating Expenses | -12.64% | -6.42% | -0.75% | -5.30% | -10.89% |
| Operating Income | 23.27% | 14.07% | 5.70% | 8.13% | 11.64% |
| Income Before Tax | 24.52% | 9.05% | -4.82% | 12.37% | 27.26% |
| Income Tax Expenses | -14.21% | -14.21% | -14.21% | -56.04% | -69.68% |
| Earnings from Continuing Operations | 24.52% | 9.05% | -4.81% | 12.41% | 27.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.52% | 9.05% | -4.81% | 12.41% | 27.32% |
| EBIT | 23.27% | 14.07% | 5.70% | 8.13% | 11.64% |
| EBITDA | 24.67% | 14.73% | 5.77% | 8.47% | 12.26% |
| EPS Basic | 23.48% | 8.22% | -5.51% | 12.28% | 27.57% |
| Normalized Basic EPS | 23.52% | 8.30% | -5.37% | 12.30% | 27.57% |
| EPS Diluted | 23.48% | 8.22% | -5.51% | 12.28% | 27.57% |
| Normalized Diluted EPS | 23.52% | 8.30% | -5.37% | 12.30% | 27.57% |
| Average Basic Shares Outstanding | -1.23% | -0.91% | -0.58% | -0.09% | 0.40% |
| Average Diluted Shares Outstanding | -1.23% | -0.91% | -0.58% | -0.09% | 0.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |